首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1541187

2024-2032 年按類型、技術、應用、最終用途和地區分類的穿戴式注射器市場報告

Wearable Injectors Market Report by Type, Technology, Application, End Use, and Region 2024-2032

出版日期: 2024年08月10日 | 出版商:

IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

IMARC Group年，全球穿戴式注射器市場規模達77億美元。由於慢性病盛行率的增加、對個人化醫療的日益關注、醫療保健成本的增加（刺激了穿戴式注射器的採用以實現高效藥物輸送）、對家庭治療方案的日益偏好、生物製藥管道的快速擴張、推動該市場正在經歷顯著成長。

穿戴式注射器市場分析：

主要市場促進因素：慢性病治療範圍的擴大以及更有針對性和更有效的給藥方法的必要性正在推動市場成長。由於更好的可用性和客製化功能而受到患者和醫護人員的歡迎，穿戴式注射設備的持續技術進步正在推動市場成長。

主要市場趨勢：開發具有穿戴式裝置的注射器的趨勢日益明顯，這些裝置配備了劑量控制和自我給藥等附加功能，從而提高了患者的便利性和治療依從性。除此之外，注射器的出現與數位健康平台和行動應用程式相結合，有助於遠端患者監測、即時資料收集和個人化醫療服務的進步，從而推動市場成長。

地理趨勢：在這些地區中，北美是穿戴式注射器的領先市場，主要是因為主要產業參與者的存在、尖端技術以及先進醫療保健技術的高採用率。由於一系列基礎設施因素，例如優惠的監管框架、不斷增加的醫療保健投資以及人們對自我管理設備的認知不斷增強，歐洲市場正在經歷大幅成長。

競爭格局：穿戴式注射器產業的一些主要市場參與者包括 Becton Dickinson and Company、CeQur SA、Debiotech SA、Dexcom Inc.、Enable Injections Inc.、Gerresheimer AG、Insulet Corporation、Tandem Diabetes Care Inc.、West Pharmaceutical Services Inc .、Ypsomed AG. 等。

挑戰與機會：市場面臨監管複雜性和報銷挑戰等挑戰，同時也提供了向以患者為中心過渡的機會。財務限制和長期臨床證據也是市場擴張的主要障礙之一。

穿戴式注射器市場趨勢：

慢性病盛行率增加

全球慢性疾病（糖尿病、癌症和心血管疾病）發生率的上升是注射器市場的主要刺激因素。從長遠來看，那些需要全職藥物管理的情況，穿戴式式注射器為患者提供了一種簡單有效的解決方案，患者可以簡單地給藥，沒有麻煩和一致性。慢性病盛行率的上升導致穿戴式注射器領域的需求成長。這些注射器為患者提供隨時隨地管理健康狀況的便利性。例如，根據國家醫學圖書館 (NLM) 的數據，近一半的美國人患有至少一種慢性疾病，約有 1.33 億人受到影響。這些資料說明了醫療保健系統的慢性病工作量不斷增加，並說明了迫切需要採取強力的管理行動，其中包括成功採用最新解決方案（例如可管理注射器），以改善患者的治療結果和生活方式。

持續的技術進步：

穿戴式注射器技術的不斷進步促進了全新的藥物輸送方法並推動了產業的成長。穿戴式科技包括與行動裝置連接、劑量監測功能和自動藥物傳輸機制等功能，最終從使用者的角度改善治療體驗和依從性。隨著更多方便用戶使用、緊湊和智慧注射器的出現，它們越來越受到人們的認可，而醫療保健提供者也能夠利用它們來制定更個人化和準確的藥物傳輸系統。穿戴式注射器對數位健康平台的直接管理進一步提高了系統的效率，使得脫離接觸的檢查和數據驅動的健康管理成為可能。例如，根據美國國家衛生研究院(NIH) 的數據，2020 年第一季度，美國遠距醫療的使用量增加了154%，到2022 年，80% 的受訪者透過遠距醫療獲得護理，高於72 % 2021 年的百分比。

人們越來越偏愛家庭治療方案：

由於快速轉向以患者為中心的醫療保健和注射器的便攜性作為診所治療的有吸引力的替代品，向家庭醫療保健的轉變正在推動市場成長。根據 IMARC GROUP 發布的報告，美國家庭醫療保健市場預計 2024 年至 2032 年的年複合成長率(CAGR) 為 7.4%。患者非常重視方便的自我給藥，並且允許他們在家中這樣做，即時見證藥物對他們健康的正面影響。慢性病管理需要持續堅持治療方案；因此，這種趨勢在這些情況下尤其突出。穿戴式注射器在醫療保健系統中發揮越來越重要的作用，因為它們允許患者控制自己的治療結果，這有助於節省醫療成本，同時提高患者的滿意度。

穿戴式注射器市場細分：

IMARC Group提供了每個細分市場的主要趨勢分析，以及 2024-2032 年全球、區域和國家層面的預測。我們的報告根據類型、技術、應用和最終用途對市場進行了分類。

按類型分類：

貼身

離體

On-body佔據大部分市場佔有率

該報告根據類型提供了詳細的市場細分和分析。這包括體內和體外。根據該報告，體用產品佔據了最大的市場佔有率。

市面上穿戴式穿戴式注射器的主要促進因素是其便利性、易用性以及提高治療順從性的潛力。這些設備設計為直接佩戴在身體上，為患者提供謹慎且免持的藥物輸送解決方案。透過消除手動注射的需要並提供可客製化的給藥方案，體內穿戴式注射器使患者能夠方便地自行給藥，而無需中斷其日常活動。此外，劑量監測和連接等先進功能的整合增強了患者的參與度，並允許醫療保健提供者進行遠端監測，進一步推動了市場上穿戴式式注射器的採用。例如，MEDTRONIC 於 2021 年 4 月推出了一款輸液器，將胰島素從幫浦輸送到體內，展示了體內穿戴式注射器技術的進步。這項創新使輸液器的佩戴時間延長了一倍，使患者可以安全地繼續胰島素幫浦治療，減少中斷和插入，同時在糖尿病管理常規中享受更大的便利和舒適。

按技術分類：

基於彈簧

馬達驅動

旋轉泵

膨脹電池

其他

Spring基佔據產業最大佔有率

報告還提供了基於該技術的詳細市場細分和分析。這包括彈簧式、馬達驅動式、旋轉幫浦、膨脹電池等。報告稱，彈簧型佔了最大的市場佔有率。

穿戴式注射器基於彈簧的原理以其簡單、可靠和經濟實惠的眾所周知的特點而建立。這些藥物使用彈簧式機械機構進行分配，使其獨立於複雜的電子設備或電源。這種消除確實降低了生產成本並提高了耐磨噴射器的耐用性和可靠性，使得它們適合長期使用。此外，彈簧注射器在藥物傳輸方面具有完美的精確度和確定性，消除了藥物水平誤差並最大限度地提高了患者的治療效果。從患者和醫療保健提供者的角度來看，這些設備因其簡單的設計和作為彈簧底座穿戴式注射器的長期經過驗證的結果而脫穎而出。例如，BECTON DICKINSON（美國公司）就是著名的創新者，BD（Libertas）提供的彈簧噴油嘴就是這樣的創新之一。這種先進的藥物傳輸系統是一種獨特的基於彈簧的發電機，可以節省電池或消除透過放電去除重金屬的情況。

按應用分類：

腫瘤學

傳染病

心血管疾病

自體免疫疾病

其他

腫瘤學代表了領先的細分市場

該報告根據應用程式提供了詳細的市場細分和分析。這包括腫瘤學、傳染病、心血管疾病、自體免疫疾病等。根據該報告，腫瘤學佔最大的部分。

腫瘤學中擴大採用穿戴式注射器，是因為患者對舒適、方便以及堅持治療方案的要求不斷提高。大多數與腫瘤疾病（癌症）作鬥爭的人通常需要長期、頻繁地服用化療藥物；身體和精神上都疲憊不堪的情況。據國家癌症研究所稱，僅 2020 年，美國就診斷出約 1,806,590 例新癌症病例，並有 606,520 人因癌症死亡。攝護腺癌、肺癌和結腸癌是主要類型，其次是其他癌症類型，在新診斷的癌症中佔很大比例。穿戴式注射器可以提供使用者友善的解決方案，確保藥物持續、受控地輸送給患者，並允許他們在醫院環境之外接受治療，例如需要靜脈注射幾個小時的癌症患者。患者的生活品質除了改善外，還可以促進治療依從性，使患者能夠定期服藥；因此，他們從這些抗癌措施中獲得了更好的結果。

按最終用途細分：

醫院和診所

居家護理

其他

居家照護在市場上表現出明顯的主導地位

報告還提供了基於最終用途的詳細市場細分和分析。這包括醫院和診所、家庭護理等。報告顯示，家庭護理佔最大的市場佔有率。

在以患者為中心的醫療保健提供技術以及對使用簡單且具有成本效益的治療方法的日益成長的需求中，使用穿戴式注射器的家庭護理環境的成長趨勢引人注目。個人協助使患者能夠在家庭環境中控制醫療狀況，提供舒適性和自主性。穿戴式注射器派上用場，因為它們有助於自我給藥，這可以防止患者由於治療的性質而必須去醫院就診。此外，結合了劑量監測和連接設備的注射器設備構成了穿戴式技術的另一項創新，這對患者的安全感具有重要影響，並使醫療保健提供者能夠進行遠端監控，從而進一步提高了它們在家庭照護中的普及。

按地區分類：

北美洲

美國

加拿大

亞太

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

北美市場領先，佔據最大的穿戴式注射器市場佔有率

該報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告稱，北美是穿戴式注射器最大的區域市場。

北美插管注射器市場的主要參與者主要是由於其擁有世界上最完善的醫療保健系統，人均醫療保健支出最高，從而使創新醫療技術很容易被廣泛接受。此外，日益成長的慢性疾病和人口老化對便利且高效的藥物輸送解決方案提出了挑戰，導致對穿戴式注射器的需求增加。最後，具有權威和技術進步的市場參與者的存在為市場的成長和創新提出了要求。此外，有利的報銷政策和有利的監管氛圍進一步推動了北美對穿戴式注射器的接受度，為全球穿戴式注射器市場做出了貢獻。例如，根據 IMARC GROUP 發布的報告，美國穿戴式注射器市場規模在 2024 年至 2032 年期間將以 5.30% 的複合年成長率成長。

競爭格局：

市場研究報告也對市場競爭格局進行了全面分析。也提供了所有主要公司的詳細資料。穿戴式注射器產業的一些主要市場參與者包括 Becton Dickinson and Company、CeQur SA、Debiotech SA、Dexcom Inc.、Enable Injections Inc.、Gerresheimer AG、Insulet Corporation、Tandem Diabetes Care Inc.、West Pharmaceutical Services Inc. 和伊普索梅德股份公司。

（請注意，這只是關鍵參與者的部分列表，報告中提供了完整列表。）

穿戴式注射器市場的主要參與者正在創新，以進一步改進功能並了解患者不斷變化的需求。一些最新的創新包括智慧型穿戴注射器的出現，這些注射器具有連接、劑量感應和自動駕駛等高階功能。此外，許多公司已經推出了具有藍牙連接功能的穿戴式注射器，使患者能夠監控其藥物攝入量並透過手機接收提醒。此外，小型化和設計的進步導致了不顯眼且更舒適的穿戴式注射器的開發，這對患者對治療的接受度和依從性產生了積極影響。這些創新凸顯了主要參與者為提供整潔的產品所做的努力，以滿足患者的生活方式和治療效果。

穿戴式注射器市場新聞：

2023 年 2 月 16 日：Insulet Corporation 收購了 Automated Glucose Control LLC (AGC) 的資產，該公司專注於自動胰島素輸送技術的開發和商業化，展示了他們對穿戴式注射器領域創新的承諾。

2023 年 3 月 17 日：Tandem 收購了輸液器開發商 Capillary Biomedical，顯示其在穿戴式注射器市場的策略性舉措。這表明 Tandem 不斷致力於透過向醫療設備供應其產品來實現創新和成長。 Tandem 對 Capillary Biomedical 的收購使其輸液器技術得以實現，並將其與其穿戴式注射器解決方案系列相結合，從而增強了其在行業中的地位。

本報告回答的關鍵問題：

迄今為止，全球穿戴式注射器市場表現如何，未來幾年將如何表現？
全球穿戴式注射器市場的促進因素、限制因素和機會是什麼？
每個促進因素、限制因素和機會對全球穿戴式注射器市場有何影響？
主要區域市場有哪些？
哪些國家代表了最具吸引力的穿戴式注射器市場？
依類型分類市場是怎麼樣的？
哪種類型是穿戴式注射器市場中最具吸引力的類型？
什麼是基於技術的市場分割？
穿戴式注射器市場中哪一項技術最具吸引力？
基於應用的市場區隔是什麼？
穿戴式注射器市場中哪項應用最具吸引力？
根據最終用途分類的市場是怎樣的？
穿戴式注射器市場中最具吸引力的最終用途是什麼？
市場競爭結構如何？
全球穿戴式注射器市場的主要參與者/公司有哪些？

本報告回答的關鍵問題：

迄今為止，全球穿戴式注射器市場表現如何，未來幾年將如何表現？
全球穿戴式注射器市場的促進因素、限制因素和機會是什麼？
每個促進因素、限制因素和機會對全球穿戴式注射器市場有何影響？
主要區域市場有哪些？
哪些國家代表了最具吸引力的穿戴式注射器市場？
依類型分類市場是怎麼樣的？
哪種類型是穿戴式注射器市場中最具吸引力的類型？
什麼是基於技術的市場分割？
穿戴式注射器市場中哪一項技術最具吸引力？
基於應用的市場區隔是什麼？
穿戴式注射器市場中哪項應用最具吸引力？
根據最終用途分類的市場是怎樣的？
穿戴式注射器市場中最具吸引力的最終用途是什麼？
市場競爭結構如何？
全球穿戴式注射器市場的主要參與者/公司有哪些？

The global wearable injectors market size reached US$ 7.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 24.4 Billion by 2032, exhibiting a growth rate (CAGR) of 13.4% during 2024-2032. The market is experiencing significant growth driven by increasing prevalence of chronic diseases, growing focus on personalized medicine, heightening healthcare costs that incentivize the adoption of wearable injectors for efficient drug delivery, rising preference for home-based treatment options, rapid expansion of biopharmaceutical pipeline, and ongoing technological advancements.

Wearable Injectors Market Analysis:

Major Market Drivers: The rising scope of chronic diseases treatments and the necessity for more targeted and effective drug delivery methods are propelling the market growth. Ongoing technological advancements in wearable injection devices due to better usability and customization features that have become popular for patients and healthcare workers are fueling market growth.

Key Market Trends: There is a growing trend to develop injectors with wearable devices equipped with additional features like dose control and self-drug delivery, thereby improving patient convenience and therapy compliance. Apart from that, the emergence of injectors combining with digital health platforms and mobile applications is contributing to the advancement of remote patient monitoring, real-time data collection, and personalized healthcare delivery, thus fueling market growth.

Geographical Trends: Among the regions, North America is the leading market for wearable injectors primarily because of the existence of major industry players, cutting- edge technology and the high adoption rate of advanced healthcare technology. The market is experiencing substantial growth in Europe owing to the set of infrastructural factors like preferential regulatory framework, rising healthcare investment, and growing awareness around self-administration devices.

Competitive Landscape: Some of the major market players in the wearable injectors industry include Becton Dickinson and Company, CeQur SA, Debiotech SA, Dexcom Inc., Enable Injections Inc., Gerresheimer AG, Insulet Corporation, Tandem Diabetes Care Inc., West Pharmaceutical Services Inc., Ypsomed AG., among many others.

Challenges and Opportunities: The market faces challenges such as the complexity of regulation and challenges with reimbursement whereas it also offers opportunities in transition to patient-centeredness. Financial limitations and long-term clinical evidence are also one of the major barriers to market expansion.

Wearable Injectors Market Trends:

Increasing prevalence of chronic diseases

The rising incidence of chronic illnesses across the globe (diabetes, cancer, and cardiovascular disorders), is the main stimulator of the injector market. Providing the long-term are those conditions that need full time medication management, and this is the wearable injectors come to offer a simple and effective solution to patients who can simply administer their medications without hassle and consistency. The rise in chronic diseases' prevalence leads to demand growth in a wearable injectors segment. These injectors provide patients with the convenience of managing their health conditions anywhere anytime. For instance, as per the NATIONAL LIBRARY OF MEDICINE (NLM), nearly half of all Americans suffer from at least one chronic disease, with approximately 133 million individuals affected. This data illustrates the increasing workload of chronic diseases for healthcare system and illustrates the pressing need for powerful management actions, among them the successful incorporation of latest solutions such as administrable injectors in order to improve patients' outcome and lifestyle.

Ongoing technological advancements:

The ongoing advancements in wearable injector technology promote completely new drug delivery methods and fuels industry growth. Wearable technologies comprise of features such as connectivity with mobile devices, dose monitoring capability, and automatic drug delivery mechanisms, which eventually improve the experience and adherence to the treatment from the user's perspective. Along with more user-friendly, compact, and intelligent injectors emerging, they are gaining more acceptance by a variety of people, while healthcare providers are being able to utilize them to formulate more individualized and accurate drug delivery systems. The direct administration of wearable injectors to digital health platforms increases the efficiencies of the system even more, making out-of-touch checkups, and data-driven health-management possible to use. For instance, according to the NATIONAL INSTITUTE OF HEALTH (NIH), in the US, there was a 154% increase in telehealth usage in the first quarter of 2020, with 80% of all respondents accessing care via telemedicine in 2022, up from 72% in 2021.

Growing preference for home-based treatment options:

The transition toward home-based healthcare due to the rapid shift to patient-centered health care and portability of injectors as an attractive alternative to clinic-based treatments is fueling market growth. The U.S. home healthcare market projected compound annual growth rate (CAGR) of 7.4 % from 2024 to 2032 as per the report published by IMARC GROUP. Patients really value the self-administration of medications that are convenient and allow them to do so at home, witnessing the positive effect on their health in real-time. Chronic disease management requires ongoing treatment regime adherence; therefore, this trend is especially prominent in those cases. Wearable injectors play an increasingly more important role in the healthcare system, as they allow patients to take control of their treatment outcomes, which helps save healthcare costs while also improving the patients' satisfaction.

Wearable Injectors Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, technology, application, and end use.

Breakup by Type:

On-body

Off-body

On-body accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the type. This includes on-body and off-body. According to the report, on-body represented the largest segment.

The on-body type of wearable injectors in the market is primarily driven by its convenience, ease of use, and potential for improved treatment adherence. These devices are designed to be worn directly on the body, providing patients with a discreet and hands-free solution for medication delivery. By eliminating the need for manual injections and offering customizable dosing schedules, On-body wearable injectors empower patients to conveniently self-administer medications without interrupting their daily activities. Additionally, the integration of advanced features such as dose monitoring and connectivity enhances patient engagement and allows for remote monitoring by healthcare providers, further driving the adoption of On-body wearable injectors in the market. For instance, MEDTRONIC launched an infusion set in April 2021 that allows for the transport of insulin from the pump to the body, showcasing advancements in on-body wearable injector technology. This innovation doubles the length of time an infusion set can be worn so that patients can safely continue on insulin pump therapy with fewer interruptions and insertions while also enjoying greater convenience and comfort in their diabetes management routine.

Breakup by Technology:

Spring-based

Motor-driven

Rotary Pump

Expanding Battery

Others

Spring-based holds the largest share of the industry

A detailed breakup and analysis of the market based on the technology have also been provided in the report. This includes spring-based, motor-driven, rotary pump, expanding battery, and others. According to the report, spring based accounted for the largest market share.

The spring-based principle of wearable injectors is established by its well-known feature of simplicity, reliability, and affordability. These medications are dispensed using spring-type mechanical mechanisms that make them independent on complex electronics or power sources. This elimination does reduce the production costs and improves the resistance and reliability of the wearable injectors such that they are applicable for long term use. Moreover, the perfect precision and certainty of spring injectors in the delivery of the drugs, eliminates drug level errors and maximizes the therapeutic outcome of patients. The devices stand out from the perspective of both patients and health care providers due to their simple design and long-term proven results as spring-base wearable injectors. For instance, BECTON DICKINSON (U.S.-based company) is a well-known innovator, and the spring-based injector offered by BD (Libertas) is one such innovation. This advanced drug delivery system is a unique spring-based power generator that saves batteries or eliminates the removal of heavy metals through discharge.

Breakup by Application:

Oncology

Infectious Diseases

Cardiovascular Diseases

Autoimmune Diseases

Others

Oncology represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the application. This includes oncology, infectious diseases, cardiovascular diseases, autoimmune diseases, and others. According to the report, oncology represented the largest segment.

The rising adoption of wearable injectors in oncology is attributed to the increasing requirements for patients to be comfortable and convenient, and to adhere to the treatment programme. Most individuals battling with oncology diseases (cancer) are often expected to take the chemotherapy drugs for long periods and in frequent doses; a situation that is both physically and emotionally exhausting. Approximately 1,806,590 new cancer cases were diagnosed, and 606,520 deaths caused by cancer happened in the USA in the year of 2020 alone as stated by the NATIONAL CANCER INSTITUTE. Prostate cancer, lung cancer, and colon cancer are the leading types, followed by other cancer types, taking up a significant percentage of new cancer diagnoses. Wearable injectors can offer a user-friendly solution by ensuring the drug is continuously and controlled delivered for patients and allowing them to receive their treatments outside the hospital environment, such as patients with cancer whose IVs will run for hours. Patients' quality of life, besides improving also facilitates treatment adherence which enables patients to take their medications regularly; hence they have better outcomes from these anti-cancer measures.

Breakup by End Use:

Hospitals and Clinics

Home Care

Others

Home care exhibits a clear dominance in the market

A detailed breakup and analysis of the market based on the end use have also been provided in the report. This includes hospitals and clinics, home care, and others. According to the report, home care accounted for the largest market share.

The growing trend of home care settings for the use of wearable injectors is notable among the patient-centric healthcare delivery techniques and the increasing demands for the use of easy and cost-effective treatment approaches. Personal assistance, which enables patients to control medical conditions in a home environment, provides comfort and autonomy. Wearable injectors come in handy as they help with self-administration of drugs, which prevents a patient from having to keep hospital visits due to the nature of his/her treatment. Moreover, injector devices that incorporate dose monitoring and connectivity equipment constitute another innovation in wearable technology which has important implications for the sense of security the patient can feel and enables remote monitoring by healthcare providers, only which further increase their popularity in home care.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest wearable injectors market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for wearable injectors.

The major players in the North American cannula injectors market are mainly due to its most sophisticated healthcare system in the world with the highest per capita healthcare spending, thus making it easy for innovative medical technologies to be widely embraced. Moreover, growing chronic diseases and an aging population posing the challenge of convenient and efficient drug delivery solutions result in an increased demand for wearable injectors. And lastly, the presence of market players with authority and technological evolution creates a requirement for growth and innovation of the market. Moreover, there is an availability of favorable reimbursement policies and conducive regulatory atmosphere which offers an extra boost for acceptance of wearable injectors in North America contributing to the global wearable injectors market. For instance, United States wearable injectors market size is exhibited to grow at a rate (CAGR) of 5.30 % during 2024-2032 as per the reports published by the IMARC GROUP.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the wearable injectors industry include Becton Dickinson and Company, CeQur SA, Debiotech SA, Dexcom Inc., Enable Injections Inc., Gerresheimer AG, Insulet Corporation, Tandem Diabetes Care Inc., West Pharmaceutical Services Inc. and Ypsomed AG.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

The key players of wearable injectors market are innovating to further improve the features and understand the changing needs of the patients. Some of the latest innovations include the emergence of smart wearable injectors that come with high-end features such as connectivity, dose sensing and auto-driving among others. Moreover, many companies have already come up with wearable injectors which have Bluetooth connectivity that enables patients to monitor their medication intake and receive a reminder through their phones. Furthermore, the miniaturization and design advancements have resulted in the development of less conspicuous and more comfortable wearable injectors which have a positive impact on the acceptance and compliance with the treatment among patients. These innovations highlight the efforts of key players to provide clutter-free products that cater for the lifestyle of patients and therapeutic outcomes.

Wearable Injectors Market News:

Feburary 16, 2023: Insulet Corporation acquired the assets of Automated Glucose Control LLC (AGC), a company focused on developing and commercializing automated insulin delivery technology, showcasing their commitment to innovation in the wearable injectors sector.

March 17, 2023: Tandem acquired infusion set developer, Capillary Biomedical, indicating their strategic moves in the wearable injectors market. This indicates that Tandem is constantly aiming for innovation and growth by supplying its products to medical devices. Tandem's acquisition of Capillary Biomedical enables its infusion set technology, which it incorporated with its line of wearable injector solutions, thus empowering its stand in the industry.

Key Questions Answered in This Report:

How has the global wearable injectors market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global wearable injectors market?
What is the impact of each driver, restraint, and opportunity on the global wearable injectors market?
What are the key regional markets?
Which countries represent the most attractive wearable injectors market?
What is the breakup of the market based on the type?
Which is the most attractive type in the wearable injectors market?
What is the breakup of the market based on technology?
Which is the most attractive technology in the wearable injectors market?
What is the breakup of the market based on the application?
Which is the most attractive application in the wearable injectors market?
What is the breakup of the market based on the end use?
Which is the most attractive end use in the wearable injectors market?
What is the competitive structure of the market?
Who are the key players/companies in the global wearable injectors market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Wearable Injectors Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 On-body
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Off-body
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Technology

7.1 Spring-based
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Motor-driven
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Rotary Pump
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Expanding Battery
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast

8 Market Breakup by Application

8.1 Oncology
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Infectious Diseases
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Cardiovascular Diseases
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Autoimmune Diseases
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast

9 Market Breakup by End Use

9.1 Hospitals and Clinics
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Home Care
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Becton Dickinson and Company
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 CeQur SA
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
- 15.3.3 Debiotech SA
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
- 15.3.4 Dexcom Inc.
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
  - 15.3.4.4 SWOT Analysis
- 15.3.5 Enable Injections Inc.
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
- 15.3.6 Gerresheimer AG
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 Financials
- 15.3.7 Insulet Corporation
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
  - 15.3.7.4 SWOT Analysis
- 15.3.8 Tandem Diabetes Care Inc.
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
- 15.3.9 West Pharmaceutical Services Inc.
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
- 15.3.10 Ypsomed AG
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 Financials
  - 15.3.10.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Wearable Injectors Market: Major Drivers and Challenges
Figure 2: Global: Wearable Injectors Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Wearable Injectors Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Wearable Injectors Market: Breakup by Type (in %), 2023
Figure 5: Global: Wearable Injectors Market: Breakup by Technology (in %), 2023
Figure 6: Global: Wearable Injectors Market: Breakup by Application (in %), 2023
Figure 7: Global: Wearable Injectors Market: Breakup by End Use (in %), 2023
Figure 8: Global: Wearable Injectors Market: Breakup by Region (in %), 2023
Figure 9: Global: Wearable Injectors (On-body) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Wearable Injectors (On-body) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Wearable Injectors (Off-body) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Wearable Injectors (Off-body) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Wearable Injectors (Spring-based) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Wearable Injectors (Spring-based) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Wearable Injectors (Motor-driven) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Wearable Injectors (Motor-driven) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Wearable Injectors (Rotary Pump) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Wearable Injectors (Rotary Pump) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Wearable Injectors (Expanding Battery) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Wearable Injectors (Expanding Battery) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Wearable Injectors (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Wearable Injectors (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Wearable Injectors (Oncology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Wearable Injectors (Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Wearable Injectors (Infectious Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Wearable Injectors (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Wearable Injectors (Cardiovascular Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Wearable Injectors (Cardiovascular Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Wearable Injectors (Autoimmune Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Wearable Injectors (Autoimmune Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Wearable Injectors (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Wearable Injectors (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Wearable Injectors (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Wearable Injectors (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Wearable Injectors (Home Care) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Wearable Injectors (Home Care) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Global: Wearable Injectors (Other End Uses) Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Global: Wearable Injectors (Other End Uses) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: North America: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: North America: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: United States: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: United States: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Canada: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Canada: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Asia-Pacific: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Asia-Pacific: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: China: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: China: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Japan: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Japan: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: India: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: India: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: South Korea: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: South Korea: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Australia: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Australia: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Indonesia: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Indonesia: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Others: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Others: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Europe: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Europe: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Germany: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Germany: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: France: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: France: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: United Kingdom: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: United Kingdom: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Italy: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Italy: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Spain: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Spain: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Russia: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Russia: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Others: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Others: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Latin America: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Latin America: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Brazil: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Brazil: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Mexico: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Mexico: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Others: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Others: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 85: Middle East and Africa: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
Figure 86: Middle East and Africa: Wearable Injectors Market: Breakup by Country (in %), 2023
Figure 87: Middle East and Africa: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 88: Global: Wearable Injectors Industry: SWOT Analysis
Figure 89: Global: Wearable Injectors Industry: Value Chain Analysis
Figure 90: Global: Wearable Injectors Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Wearable Injectors Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Wearable Injectors Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Wearable Injectors Market Forecast: Breakup by Technology (in Million US$), 2024-2032
Table 4: Global: Wearable Injectors Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 5: Global: Wearable Injectors Market Forecast: Breakup by End Use (in Million US$), 2024-2032
Table 6: Global: Wearable Injectors Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Wearable Injectors Market: Competitive Structure
Table 8: Global: Wearable Injectors Market: Key Players

02-2729-4219

+886-2-2729-4219